These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35885064)

  • 1. Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status.
    Koníčková D; Menšíková K; Tučková L; Hényková E; Strnad M; Friedecký D; Stejskal D; Matěj R; Kaňovský P
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the role of cerebrospinal fluid as analyte in neurologic disorders.
    Pingle SC; Lin F; Anekoji MS; Patro CPK; Datta S; Jones LD; Kesari S; Ashili S
    Future Sci OA; 2023 Apr; 9(4):FSO851. PubMed ID: 37090492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.
    Shaw LM; Korecka M; Clark CM; Lee VM; Trojanowski JQ
    Nat Rev Drug Discov; 2007 Apr; 6(4):295-303. PubMed ID: 17347655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges.
    Kim D; Kim YS; Shin DW; Park CS; Kang JH
    J Clin Neurol; 2016 Oct; 12(4):381-392. PubMed ID: 27819412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal Fluid and MRI Biomarkers in Neurodegenerative Diseases: A Retrospective Memory Clinic-Based Study.
    Kaipainen A; Jääskeläinen O; Liu Y; Haapalinna F; Nykänen N; Vanninen R; Koivisto AM; Julkunen V; Remes AM; Herukka SK
    J Alzheimers Dis; 2020; 75(3):751-765. PubMed ID: 32310181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases.
    Doroszkiewicz J; Groblewska M; Mroczko B
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer's Disease and Parkinson's Disease.
    Pawlik P; Błochowiak K
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33671562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice.
    Blennow K; Biscetti L; Eusebi P; Parnetti L
    Mov Disord; 2016 Jun; 31(6):836-47. PubMed ID: 27145480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF biomarkers in neurodegenerative and vascular dementias.
    Llorens F; Schmitz M; Ferrer I; Zerr I
    Prog Neurobiol; 2016; 138-140():36-53. PubMed ID: 27016008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.
    Obrocki P; Khatun A; Ness D; Senkevich K; Hanrieder J; Capraro F; Mattsson N; Andreasson U; Portelius E; Ashton NJ; Blennow K; Schöll M; Paterson RW; Schott JM; Zetterberg H
    Alzheimers Res Ther; 2020 Feb; 12(1):20. PubMed ID: 32111242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF biomarkers in neurodegenerative diseases.
    Mattsson N
    Clin Chem Lab Med; 2011 Mar; 49(3):345-52. PubMed ID: 21303297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoproteins as diagnostic and prognostic biomarkers for neurodegenerative diseases: A glycoproteomic approach.
    Xu MM; Zhou MT; Li SW; Zhen XC; Yang S
    J Neurosci Res; 2021 May; 99(5):1308-1324. PubMed ID: 33634546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics of neurodegenerative diseases.
    Botas A; Campbell HM; Han X; Maletic-Savatic M
    Int Rev Neurobiol; 2015; 122():53-80. PubMed ID: 26358890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Study of Cerebrospinal Fluid microRNAs in Spinal Cord Injury and Neurodegenerative Diseases: Methodological Problems and Possible Solutions.
    Baichurina I; Valiullin V; James V; Rizvanov A; Mukhamedshina Y
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.
    Kroksveen AC; Opsahl JA; Aye TT; Ulvik RJ; Berven FS
    J Proteomics; 2011 Apr; 74(4):371-88. PubMed ID: 21111852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Tau beyond Alzheimer's Disease: A Narrative Review.
    Virgilio E; De Marchi F; Contaldi E; Dianzani U; Cantello R; Mazzini L; Comi C
    Biomedicines; 2022 Mar; 10(4):. PubMed ID: 35453510
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.